The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality

Name: The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality
Published: 2005
License: Public Domain

King's College Hospital NHS Trust · 2005

ClinicalTrials.gov · Datasets · License: Public Domain · 2005

Open Source ↗

myelodysplastic syndromes, lenalidomide, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality

Related documents